Demo Day 2015: Better Vaccines
Channel: UNeMed Corporation
Date: 2015-11-02

CEO Sam Al-Murani will outline Prommune's approach to boost innate immune systems to fight disease and infection. Prommune has developed novel immune stimulating peptides that are derived from a naturally-occurring protein component of the immune system. Prommune's initial product is a Swine Influenza A virus vaccine that is currently undergoing clinical testing in pigs. Successful implementation could produce a dramatic impact to the hog farming industry, and perhaps lead to further clinical studies toward advancing the technology for use in humans.